A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)
Clinical trial NCT06699355 · COMPLETED
Trial details
- NCT number
- NCT06699355
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-08
- Primary completion
- 2023-12-29
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.